MOCHIDA PHARMACEUTICAL CO., LTD. based in TOKYO, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-05-07

US20260124171A1

Human necessities

PHARMACEUTICAL DRUG CONTAINING HETEROCYCLIDENE ACETAMIDE DERIVATIVE

#2 | 2026-04-02

US20260091018A1

Human necessities

COMBINATION PREPARATION CONTAINING HETEROCYCLIDENE ACETAMIDE DERIVATIVE

#3 | 2026-01-15

US20260014294A1

Human necessities

NERVE REGENERATION-INDUCING MATERIAL

#4 | 2025-12-11

US20250376792A1

Textiles; paper

GEL FIBER MANUFACTURING APPARATUS AND MANUFACTURING METHOD

#5 | 2025-08-07

US20250250246A1

Chemistry; metallurgy

METHOD FOR PRODUCING HETEROCYCLIDENE ACETAMIDE DERIVATIVE

#6 | 2025-05-08

US20250144267A1

Human necessities

USE OF POLYSACCHARIDE DERIVATIVE

#7 | 2025-05-01 ✅ Patent 12,502,375 granted on 2025-12-23

US20250134854A1

Human necessities

PHARMACEUTICAL DRUG CONTAINING HETEROCYCLIDENE ACETAMIDE DERIVATIVE

#8 | 2025-05-01 ✅ Patent 12,527,740 granted on 2026-01-20

US20250134808A1

Human necessities

SUSPENSION CONTAINING HETEROCYCLIDENE ACETAMIDE DERIVATIVE

#9 | 2025-04-10

US20250114085A1

Human necessities

BODY-CAVITY SHEET APPLYING DEVICE AND SHEET APPLYING METHOD

#10 | 2025-01-30

US20250032681A1

Human necessities

ANTI-ADHESION COMPOSITION

#11 | 2024-12-19

US20240417384A1

Chemistry; metallurgy

CRYSTALS OF TETRAHYDRONAPHTHYL UREA DERIVATIVE

#12 | 2024-10-24

US20240350711A1

Human necessities

TREATED CELL MATERIAL USED IN BIOLOGICAL TISSUE REPAIR

#13 | 2024-10-17

US20240342340A1

Human necessities

MULTILAYER STRUCTURE USING CHEMICALLY CROSSLINKED ALGINIC ACID

#14 | 2024-09-26

US20240316248A1

Human necessities

TRANSPLANTATION DEVICE USING CHEMICALLY CROSSLINKED ALGINIC ACID

#15 | 2024-08-01

US20240252646A1

Human necessities

SELF-EMULSIFYING COMPOSITION OF OMEGA-3 FATTY ACID

#16 | 2024-07-11

US20240226137A1

Human necessities

ALGINATE LIQUID PREPARATION

#17 | 2024-06-06 ✅ Patent 12,564,553 granted on 2026-03-03

US20240180827A1

Human necessities

SUSPENSION CONTAINING HETEROCYCLIDENE ACETAMIDE DERIVATIVE

#18 | 2024-05-30 ✅ Patent 12,312,574 granted on 2025-05-27

US20240174959A1

Chemistry; metallurgy

Polymer-coated crosslinked alginate gel fiber

#19 | 2024-05-30 ✅ Patent 12,649,799 granted on 2026-06-09

US20240174772A1

Chemistry; metallurgy

NOVEL CROSSLINKED ALGINIC ACID

#20 | 2024-04-25

US20240132854A1

Chemistry; metallurgy

NOVEL MULTILAYER POLYMER-COATED CROSSLINKED ALGINATE GEL FIBER

#21 | 2023-09-14

US20230285577A1

Human necessities

POLYSACCHARIDE DERIVATIVE, POLYSACCHARIDE DERIVATIVE-DRUG CONJUGATE, AND METHOD FOR PRODUCING SAME

#22 | 2023-07-06 ✅ Patent 12,151,025 granted on 2024-11-26

US20230210777A1

Chemistry; metallurgy

Freeze-dried alginic acid preparation

#23 | 2023-06-22

US20230190943A1

Human necessities

ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND

#24 | 2023-05-11 ✅ Patent 11,890,145 granted on 2024-02-06

US20230145308A1

Human necessities

Adhesion-preventing composition

#25 | 2023-02-16 ✅ Patent 12,491,208 granted on 2025-12-09

US20230045844A1

Human necessities

COMBINATION AND METHOD FOR TREATING SUBJECT USING ALGINATE

#26 | 2023-02-09 ✅ Patent 12,349,886 granted on 2025-07-08

US20230041137A1

Human necessities

RETRACTOR

#27 | 2023-02-02 ✅ Patent 12,617,905 granted on 2026-05-05

US20230035986A1

Chemistry; metallurgy

NOVEL CROSSLINKED ALGINIC ACID

#28 | 2022-12-29

US20220409773A1

Human necessities

TRANSPLANTATION DEVICE USING CHEMICALLY CROSSLINKED ALGINIC ACID

#29 | 2022-12-15 ✅ Patent 12,479,933 granted on 2025-11-25

US20220396643A1

Chemistry; metallurgy

NOVEL CROSSLINKED ALGINIC ACID STRUCTURE

#30 | 2022-11-24 ✅ Patent 12,533,337 granted on 2026-01-27

US20220370404A1

Human necessities

PHARMACEUTICAL DRUG CONTAINING HETEROCYCLIDENE ACETAMIDE DERIVATIVE

#31 | 2022-11-03 ✅ Patent 12,134,607 granted on 2024-11-05

US20220348552A1

Chemistry; metallurgy

Crystals of tetrahydronaphthyl urea derivative

#32 | 2022-09-08

US20220280468A1

Human necessities

METHOD FOR PREVENTING OCCURRENCE OF CARDIOVASCULAR EVENT IN MULTIPLE RISK PATIENT

#33 | 2022-06-23 ✅ Patent 12,478,637 granted on 2025-11-25

US20220193118A1

Human necessities

METHOD FOR SUPPRESSING INTERVERTEBRAL DISC PAIN

#34 | 2022-01-13 ✅ Patent 12,286,414 granted on 2025-04-29

US20220009898A1

Chemistry; metallurgy

Method for producing heterocyclidene acetamide derivative

#35 | 2021-12-09 ✅ Patent 11,472,891 granted on 2022-10-18

US20210380727A1

Chemistry; metallurgy

Photocrosslinkable alginic acid derivative

#36 | 2021-12-09

US20210379004A1

Human necessities

METHOD FOR PREVENTING OCCURRENCE OF CARDIOVASCULAR EVENT IN MULTIPLE RISK PATIENT

#37 | 2021-12-09

US20210378650A1

Human necessities

BODY-CAVITY SHEET APPLYING DEVICE AND SHEET APPLYING METHOD

#38 | 2021-11-04

US20210340481A1

Chemistry; metallurgy

ALGINATE HOLLOW MICROFIBER

#39 | 2021-09-16

US20210283304A1

Human necessities

NERVE REGENERATION-INDUCING MATERIAL

#40 | 2021-09-02

US20210267927A1

Human necessities

SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID

#41 | 2021-06-24

US20210186882A1

Human necessities

FREEZE-DRIED ALGINIC ACID PREPARATION

#42 | 2021-06-10

US20210169837A1

Human necessities

COMPOSITION FOR REDUCING NEW-ONSET DIABETES

#43 | 2021-05-06

US20210128510A1

Human necessities

SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID

#44 | 2021-04-15 ✅ Patent 11,685,788 granted on 2023-06-27

US20210107990A1

Chemistry; metallurgy

Anti-presepsin antibody

#45 | 2021-04-01 ✅ Patent 11,932,708 granted on 2024-03-19

US20210095053A1

Chemistry; metallurgy

Crosslinked alginic acid

#46 | 2021-02-04 ✅ Patent 11,648,229 granted on 2023-05-16

US20210030707A1

Human necessities

Composition containing eicosapentaenoic acid alkyl ester, and method for producing same

#47 | 2021-01-28 ✅ Patent 11,472,892 granted on 2022-10-18

US20210024659A1

Chemistry; metallurgy

Reactive alginic acid derivatives

#48 | 2021-01-07

US20210000968A1

Human necessities

ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND

#49 | 2020-12-24

US20200397954A1

Human necessities

ANTI-ADHESION COMPOSITION

#50 | 2020-12-17

US20200390893A1

Human necessities

SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID

#51 | 2020-11-05 ✅ Patent 11,911,480 granted on 2024-02-27

US20200345852A1

Human necessities

Self-emulsifying composition of ω-3 fatty acid

#52 | 2020-10-01 ✅ Patent 11,325,895 granted on 2022-05-10

US20200308136A1

Chemistry; metallurgy

Crystals of tetrahydronaphthyl urea derivative

#53 | 2020-09-17 ✅ Patent 12,478,636 granted on 2025-11-25

US20200289547A1

Human necessities

COMPOSITION FOR TREATING INTERVERTEBRAL DISC

#54 | 2020-08-27 ✅ Patent 12,226,544 granted on 2025-02-18

US20200268931A1

Human necessities

Brain damage recovery material

#55 | 2020-08-06

US20200246299A1

Human necessities

EMULSION AND EMULSION PRECONCENTRATE COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS AND USES THEREOF

#56 | 2020-07-30 ✅ Patent 10,927,079 granted on 2021-02-23

US20200239419A1

Chemistry; metallurgy

Intermediate compound of novel tetrahydronaphthyl urea derivative

#57 | 2020-07-16 ✅ Patent 10,864,185 granted on 2020-12-15

US20200222356A1

Human necessities

Composition containing eicosapentaenoic acid alkyl ester, and method for producing same

#58 | 2020-03-05 ✅ Patent 11,969,437 granted on 2024-04-30

US20200069726A1

Human necessities

Alginate liquid preparation

#59 | 2020-02-13 ✅ Patent 11,207,286 granted on 2021-12-28

US20200046672A1

Human necessities

Self-emulsifying composition of w3 fatty acid

#60 | 2020-01-30 ✅ Patent 11,426,425 granted on 2022-08-30

US20200030367A1

Human necessities

Composition for treating fibrocartilage tissue damage

#61 | 2019-11-28

US20190358186A1

Human necessities

COMPOSITION FOR REDUCING NEW-ONSET DIABETES

#62 | 2019-11-07 ✅ Patent 10,669,239 granted on 2020-06-02

US20190337897A1

Chemistry; metallurgy

Tetrahydronaphthyl urea derivative

#63 | 2019-08-01

US20190231731A1

Human necessities

SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID

#64 | 2019-07-11 ✅ Patent 11,464,597 granted on 2022-10-11

US20190209260A1

Human necessities

Adhesion-preventing composition

#65 | 2019-06-06 ✅ Patent 10,786,575 granted on 2020-09-29

US20190167802A1

Human necessities

Self-emulsifying composition of Ω3 fatty acid

#66 | 2019-03-21 ✅ Patent 11,052,174 granted on 2021-07-06

US20190083678A1

Human necessities

Nerve regeneration-inducing material

#67 | 2019-03-07

US20190071441A1

Chemistry; metallurgy

PYRAZOLE DERIVATIVE MANUFACTURING METHOD

#68 | 2019-01-24 ✅ Patent 10,399,945 granted on 2019-09-03

US20190023657A1

Chemistry; metallurgy

Tetrahydronaphthyl urea derivative

#69 | 2018-12-27 ✅ Patent 10,493,052 granted on 2019-12-03

US20180369185A1

Human necessities

Self-emulsifying composition of ω3 fatty acid

#70 | 2018-12-06 ✅ Patent 10,208,010 granted on 2019-02-19

US20180346436A1

Chemistry; metallurgy

Crystal of a heterocyclidene acetamide derivative

#71 | 2018-11-29 ✅ Patent 10,966,929 granted on 2021-04-06

US20180338921A1

Human necessities

Freeze-dried alginic acid preparation

#72 | 2018-08-23 ✅ Patent 11,117,974 granted on 2021-09-14

US20180237537A1

Chemistry; metallurgy

Specifically purified anti-presepsin antibody

#73 | 2018-08-16 ✅ Patent 10,201,531 granted on 2019-02-12

US20180228776A1

Human necessities

Indazolyl-oxo-isothiazole compounds

#74 | 2018-07-19 ✅ Patent 10,676,532 granted on 2020-06-09

US20180201688A1

Chemistry; metallurgy

Anti-presepsin antibody

#75 | 2018-05-31 ✅ Patent 10,105,340 granted on 2018-10-23

US20180147176A1

Human necessities

Composition containing eicosapentaenoic acid alkyl ester, and method for producing same

#76 | 2018-04-12 ✅ Patent 10,174,025 granted on 2019-01-08

US20180099964A1

Chemistry; metallurgy

Pyrazole derivative manufacturing method

#77 | 2018-02-01 ✅ Patent 10,189,819 granted on 2019-01-29

US20180030036A1

Chemistry; metallurgy

Factor IXa inhibitors

#78 | 2018-01-18

US20180015038A1

Human necessities

OMEGA-3 FATTY ACID SELF-EMULSIFYING COMPOSITION

#79 | 2017-12-28 ✅ Patent 10,758,622 granted on 2020-09-01

US20170368184A1

Human necessities

Self-emulsifying composition of omega-3 fatty acid

#80 | 2017-12-07

US20170348273A1

Human necessities

SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID

#81 | 2017-12-07

US20170348268A1

Human necessities

SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID

#82 | 2017-10-26 ✅ Patent 10,668,038 granted on 2020-06-02

US20170304249A1

Human necessities

Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed

#83 | 2017-09-28

US20170273929A1

Human necessities

CARDIOVASCULAR DISEASE PRIMARY PREVENTION AGENT FOR PATIENTS HAVING HIGH BLOOD LEVELS OF HIGH-SENSITIVITY C-REACTIVE PROTEIN

#84 | 2017-09-28 ✅ Patent 10,716,775 granted on 2020-07-21

US20170273928A1

Human necessities

Composition for preventing the occurrence of cardiovascular event in multiple risk patient

#85 | 2017-09-07 ✅ Patent 9,918,953 granted on 2018-03-20

US20170252315A1

Human necessities

Composition containing eicosapentaenoic acid alkyl ester, and method for producing same

#86 | 2017-08-03 ✅ Patent 9,879,009 granted on 2018-01-30

US20170217958A1

Chemistry; metallurgy

Pyrazole derivative manufacturing method

#87 | 2017-07-27 ✅ Patent 9,902,723 granted on 2018-02-27

US20170210740A1

Chemistry; metallurgy

Pyrazole derivative manufacturing method

#88 | 2017-06-01 ✅ Patent 9,700,537 granted on 2017-07-11

US20170151206A1

Human necessities

Composition for preventing the occurrence of cardiovascular event in multiple risk patient

#89 | 2017-06-01 ✅ Patent 9,789,068 granted on 2017-10-17

US20170151178A1

Human necessities

Easily dosable solid preparation

#90 | 2017-05-11 ✅ Patent 9,969,724 granted on 2018-05-15

US20170129880A1

Chemistry; metallurgy

Factor IXa inhibitors

#91 | 2017-05-04 ✅ Patent 10,092,536 granted on 2018-10-09

US20170119724A1

Human necessities

Self-emulsifying composition of ω3 fatty acid

#92 | 2017-03-23

US20170079946A1

Human necessities

COMPOSITION FOR REDUCING NEW-ONSET DIABETES

#93 | 2017-02-02 ✅ Patent 9,808,445 granted on 2017-11-07

US20170027916A1

Human necessities

Factor IXa inhibitors

#94 | 2016-12-29 ✅ Patent 10,852,302 granted on 2020-12-01

US20160377615A1

Physics

Method for evaluation of function of phagocyte

#95 | 2016-12-01 ✅ Patent 9,777,000 granted on 2017-10-03

US20160347751A1

Chemistry; metallurgy

Pyrazole derivative

#96 | 2016-06-16 ✅ Patent 10,054,585 granted on 2018-08-21

US20160169889A1

Physics

Diagnosis of respiratory tract infectious disease using urine specimens

#97 | 2016-06-09 ✅ Patent 10,024,869 granted on 2018-07-17

US20160161506A1

Physics

Diagnosis of respiratory tract infectious disease using blood specimens

#98 | 2016-06-09

US20160158184A1

Human necessities

SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID

#99 | 2016-06-02 ✅ Patent 9,801,843 granted on 2017-10-31

US20160151319A1

Human necessities

Self-emulsifying composition of ω3 fatty acid

#100 | 2016-03-31

US20160089355A1

Human necessities

COMPOSITION FOR PREVENTING THE OCCURRENCE OF CARDIOVASCULAR EVENT IN MULTIPLE RISK PATIENT

Also check out MOCHIDA PHARMACEUTICAL CO., LTD.'s (Tokyo, Japan) applicant profile with 94 patent applications submitted.

AssigneeID:

13927 ⎘